Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-103965
Filing Date
2024-09-05
Accepted
2024-09-05 16:02:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 prosupp_for_warrant_indu.htm 424B3 183597
2 GRAPHIC img192991806_0.jpg GRAPHIC 933834
  Complete submission text file 0000950170-24-103965.txt   1454270
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281745 | Film No.: 241281365
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)